Atea Pharmaceuticals (AVIR) Times Interest Earned (2019 - 2026)
Atea Pharmaceuticals' (AVIR) quarterly Times Interest Earned came in at -$1.81 in Q1 2026, up 77.43% year-on-year from -$1.02 in Q1 2025, and up 99.86% quarter-over-quarter from -$1248.5 in Q4 2025.
Atea Pharmaceuticals (AVIR) Times Interest Earned (2019 - 2026) Analysis & Trends
Atea Pharmaceuticals' Times Interest Earned history runs 8 years deep, the most recent figure standing at -$1.81 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 77.43% year-over-year to -$1.81 in Q1 2026; TTM through Mar 2026 was -$7.14, a 78.52% increase from a year earlier, with the FY2025 full-year figure at -$21.44, down 1202.58% from the prior year.
- Times Interest Earned advanced to -$1.81 in Q1 2026 per AVIR's latest filing, from -$1248.5 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$1.81 in Q1 2026 and bottomed at -$1248.5 in Q4 2025.
- The 5-year median for Times Interest Earned is -$105.51 (2023), against an average of -$234.07.
- Across the five-year window, Times Interest Earned plunged 324.24% in 2022 and surged 96.8% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$511.53 in 2022, then plunged by 37.95% to -$705.65 in 2023, then rose by 28.18% to -$506.83 in 2024, then slumped by 146.33% to -$1248.5 in 2025, then jumped by 99.86% to -$1.81 in 2026.
- Per Business Quant, the three latest AVIR Times Interest Earned figures stand at -$1.81 (Q1 2026), -$1248.5 (Q4 2025), and -$9.94 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Atea Pharmaceuticals | 376.19 Mn | 376.19 Mn | - | -1.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.81 |
| Dec 31, 2025 | -1,248.50 |
| Sep 30, 2025 | -9.94 |
| Jun 30, 2025 | -4.77 |
| Mar 31, 2025 | -8.00 |
| Dec 31, 2024 | -506.83 |
| Sep 30, 2024 | -6.10 |
| Jun 30, 2024 | -7.87 |
| Mar 31, 2024 | -8.15 |
| Dec 31, 2023 | -705.65 |
| Sep 30, 2023 | -8.30 |
| Jun 30, 2023 | -246.40 |
| Mar 31, 2023 | -105.51 |
| Dec 31, 2022 | -511.53 |
| Sep 30, 2022 | -167.85 |
| Jun 30, 2022 | -256.31 |
| Mar 31, 2022 | -175.73 |
| Dec 31, 2021 | 1,289.16 |
| Sep 30, 2021 | -217.13 |
| Jun 30, 2021 | 114.30 |